HomeFRX • TSE
add
Fennec Pharmaceuticals Inc
Previous close
$6.59
Day range
$6.85 - $7.68
Year range
$5.65 - $15.43
Market cap
201.74M CAD
Avg Volume
1.50K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
.INX
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 6.97M | 7.05% |
Operating expense | 10.82M | 50.24% |
Net income | -5.74M | -207.18% |
Net profit margin | -82.23 | -186.92% |
Earnings per share | -0.29 | -317.70% |
EBITDA | -5.18M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 40.32M | 225.19% |
Total assets | 58.92M | 209.65% |
Total liabilities | 64.09M | 116.83% |
Total equity | -5.17M | — |
Shares outstanding | 27.43M | — |
Price to book | -34.68 | — |
Return on assets | -21.31% | — |
Return on capital | -45.34% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -5.74M | -207.18% |
Cash from operations | -2.21M | 20.07% |
Cash from investing | — | — |
Cash from financing | -528.00K | -362.69% |
Net change in cash | -2.73M | -6.84% |
Free cash flow | -874.00K | 62.63% |
About
Founded
1996
Headquarters
Website
Employees
29